DiscoverCNS[podcast] To detect TB is to fight TB: Diagnosis is critical entry point to TB care pathway
[podcast] To detect TB is to fight TB: Diagnosis is critical entry point to TB care pathway

[podcast] To detect TB is to fight TB: Diagnosis is critical entry point to TB care pathway

Update: 2023-09-09
Share

Description

<iframe allowfullscreen="" frameborder="0" height="30" mozallowfullscreen="true" src="https://archive.org/embed/sumit-podcast" webkitallowfullscreen="true" width="470"></iframe>
This podcast features Sumit Mitra, President of Global Sales and Marketing, Molbio Diagnostics, who asserts "To detect TB is to fight TB." Diagnosis is critical entry point to TB care pathway and towards #EndTB, he says. As per Government's 2021 and 2022 India TB Reports, Molbio's Truenat molecular test, was the most used molecular test in India to diagnose TB among those with presumptive TB, and detect drug resistance upfront. It is currently rolled out in over 40 countries - most of them are high TB burden nations in Asia and Africa. Apart from accurately diagnosing TB within an hour, Truenat molecular test is also effective in diagnosing a range of ~40 diseases, such as, malaria, HIV (viral load), hepatitis B virus (HBV), hepatitis C virus (HCV), human papilloma virus (HPV), dengue, sexually transmitted diseases (STDs), among others.

Listen to this podcast on Apple Podcasts, Amazon Music, Google Podcasts, Spotify, TuneIn, Podtail, BluBrry, Himalaya, ListenNotes, American Podcasts, CastBox FM, Ivy FM, Player FM, and other podcast streaming platforms.

Thanks

CNS team
Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

[podcast] To detect TB is to fight TB: Diagnosis is critical entry point to TB care pathway

[podcast] To detect TB is to fight TB: Diagnosis is critical entry point to TB care pathway

CNS www.citizen-news.org